<SEC-DOCUMENT>0001193125-23-030315-index.html : 20230209 <SEC-HEADER>0001193125-23-030315.hdr.sgml : 20230209 <ACCEPTANCE-DATETIME>20230209171039 ACCESSION NUMBER: 0001193125-23-030315 CONFORMED SUBMISSION TYPE: S-3ASR PUBLIC DOCUMENT COUNT: 7 FILED AS OF DATE: 20230209 DATE AS OF CHANGE: 20230209 EFFECTIVENESS DATE: 20230209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-3ASR SEC ACT: 1933 Act SEC FILE NUMBER: 333-269670 FILM NUMBER: 23607267 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 </SEC-HEADER> <DOCUMENT> <TYPE>S-3ASR <SEQUENCE>1 <FILENAME>d416616ds3asr.htm <DESCRIPTION>S-3ASR <TEXT> Document 1 - file: d416616ds3asr.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>d416616dex51.htm <DESCRIPTION>EX-5.1 <TEXT> Document 2 - file: d416616dex51.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>d416616dex231.htm <DESCRIPTION>EX-23.1 <TEXT> Document 3 - file: d416616dex231.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-25.1 <SEQUENCE>4 <FILENAME>d416616dex251.htm <DESCRIPTION>EX-25.1 <TEXT> Document 4 - file: d416616dex251.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-FILING FEES <SEQUENCE>5 <FILENAME>d416616dexfilingfees.htm <DESCRIPTION>EX-FILING FEES <TEXT> Document 5 - file: d416616dexfilingfees.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>6 <FILENAME>g416616lw1.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 6 - file: g416616lw1.jpg
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>7 <FILENAME>g416616lw2.jpg <DESCRIPTION>GRAPHIC <TEXT> Document 7 - file: g416616lw2.jpg
</DOCUMENT> </SEC-DOCUMENT>